THC · NYSE
Tenet Healthcare (THC) Stock Price & Fundamentals
Tenet Healthcare (THC) closed at $699.62 on Oct 9, 2026, up 0.82% from the previous close of $693.91.
Share price, past year
1Y +20.11%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $699.62 |
| Sep 30, 2026 | $675.65 |
| Aug 31, 2026 | $673.34 |
| Jul 31, 2026 | $618.93 |
| Jun 30, 2026 | $581.72 |
| May 29, 2026 | $625.88 |
| Apr 30, 2026 | $602.37 |
| Mar 31, 2026 | $600.38 |
| Feb 27, 2026 | $589.11 |
| Jan 30, 2026 | $565.86 |
| Dec 31, 2025 | $564.08 |
| Nov 28, 2025 | $539.31 |
| Oct 31, 2025 | $573.68 |
Key statistics
- Market cap
- $56.33B
- P/E (TTM)
- 27.0
- EPS (TTM)
- $25.93
- Revenue (TTM)
- $21.81B
- Net income (TTM)
- —
- Shares outstanding
- 80.5M
- Dividend yield
- —
- 52-week range
- $532.24 – $702.49
Tenet Healthcare's market cap is $56.33B, based on a share price of $699.62 and 80.5M shares outstanding as of Jul 24, 2026.
Financials
Tenet Healthcare reported revenue of $21.31B for fiscal 2025, up 3.07% from fiscal 2024.
Tenet Healthcare reported net income of $1.12B in fiscal 2010.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $21.31B | +3.1% | — | — | $15.49 | $2.53B |
| FY2024ended Dec 31, 2024 | $20.68B | +0.5% | — | — | $32.70 | $1.12B |
| FY2023ended Dec 31, 2023 | $20.56B | +7.3% | — | — | $5.71 | $1.62B |
| FY2022ended Dec 31, 2022 | $19.17B | −1.6% | — | — | $3.79 | $321.00M |
| FY2021ended Dec 31, 2021 | $19.49B | +10.5% | — | — | $8.42 | $910.00M |
| FY2020ended Dec 31, 2020 | $17.64B | −4.5% | — | — | $3.75 | $2.87B |
| FY2019ended Dec 31, 2019 | $18.48B | +0.9% | — | — | −$2.08 | $563.00M |
| FY2018ended Dec 31, 2018 | $18.31B | −4.5% | — | — | $1.00 | $432.00M |
| FY2017ended Dec 31, 2017 | $19.18B | −2.3% | — | — | −$7.00 | $493.00M |
| FY2016ended Dec 31, 2016 | $19.62B | — | — | — | −$1.93 | −$317.00M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $5.63B | — | $9.84 |
| Q1 FY2026ended Mar 31, 2026 | $5.37B | — | $8.01 |
| Q4 FY2025ended Dec 31, 2025 | $5.53B | — | $4.22 |
| Q3 FY2025ended Sep 30, 2025 | $5.29B | — | $3.86 |
| Q2 FY2025ended Jun 30, 2025 | $5.27B | — | $3.14 |
| Q1 FY2025ended Mar 31, 2025 | $5.22B | — | $4.27 |
| Q4 FY2024ended Dec 31, 2024 | $5.07B | — | $3.79 |
| Q3 FY2024ended Sep 30, 2024 | $5.13B | — | $4.89 |
Company profile
- Name
- Tenet Healthcare Corporation
- Ticker
- THC
- Exchange
- NYSE
- Industry (SEC SIC)
- Services-General Medical & Surgical Hospitals, NEC
- Headquarters
- 14201 Dallas Parkway, Dallas, TX 75254
- Incorporated in
- NV
- Fiscal year ends
- December
- SEC CIK
- 0000070318
Recent SEC filings
- Sep 22, 2026
- Sep 8, 2026
- Jul 29, 2026
- Jul 23, 2026
- May 29, 2026
- Apr 30, 2026
- Apr 30, 2026
- Apr 10, 2026
Frequently asked questions
What is Tenet Healthcare's stock price?
Tenet Healthcare (THC) closed at $699.62 on Oct 9, 2026, up 0.82% from the previous close of $693.91.
What is Tenet Healthcare's market cap?
Tenet Healthcare's market cap is $56.33B, based on a share price of $699.62 and 80.5M shares outstanding as of Jul 24, 2026.
How much revenue does Tenet Healthcare make?
Tenet Healthcare reported revenue of $21.31B for fiscal 2025, up 3.07% from fiscal 2024.
What is THC's P/E ratio?
Tenet Healthcare's price-to-earnings ratio is 27.0, based on trailing twelve-month diluted EPS of $25.93.
Does Tenet Healthcare pay a dividend?
Tenet Healthcare's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Tenet Healthcare Corporation's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures